$14.89
0.010.07%
At close: May 26, 5:00 PM EST
$14.89
N/A
After Hours: 4:31 PM EST
Anika Therapeutics Inc Earnings Estimates
ANIKNASDAQ
Anika Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:ANIK
Anika Therapeutics (ANIK) is scheduled to report Q2 earnings on July 29, 2026. Analysts estimate EPS of $-0.01 and quarterly revenue of $29.22M.
In the most recent quarter (Q1), Anika Therapeutics reported EPS of $0.27, beating estimates of $-0.04 by 7.75%. Revenue came in at $29.61M, exceeding the estimate of $28.14M by 0.05%.
Anika Therapeutics has beaten EPS estimates in 4 consecutive quarters.
Over the last 4 quarters, Anika Therapeutics has averaged an EPS surprise of 3.99% and a revenue surprise of 0.04%.
Earnings Date
Jul 29
EPS Estimate
$-0.010
Quarterly Revenue Estimate
$29.22M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$116.26M
Anika Therapeutics Earnings History
Analyze the earnings history of Anika Therapeutics using advanced sorting and filters.
Loading calendar...
Anika Therapeutics (ANIK) Earnings Per Share
The chart below shows Anika Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Anika Therapeutics (ANIK) Revenue
The chart below shows Anika Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Anika Therapeutics (NASDAQ:ANIK) reporting earnings?
Anika Therapeutics (ANIK) is scheduled to report earnings on July 29, 2026. The last reported earnings were for reported on April 29, 2026 for Q1.
What were the latest earnings per share (EPS) for Anika Therapeutics (NASDAQ:ANIK)?
The Actual EPS was $0.27, which beat the estimate of $-0.04.
What were Anika Therapeutics’s (NASDAQ:ANIK) revenues?
The Actual Revenue was $29.61M, which beat the estimate of $28.14M.
